Core Viewpoint - The company "沪上阿姨" successfully listed on the Hong Kong Stock Exchange, becoming the fifth tea beverage company to do so, with a strong IPO subscription demand and significant initial trading gains [1][2]. Group 1: Company Overview - "沪上阿姨" was founded in 2013 and gained popularity with its "blood glutinous rice milk tea" [2]. - As of the end of 2023, the company operates the fifth and fourth largest network of ready-to-drink tea shops in China, with a significant presence in lower-tier markets [2]. - The company has over 9,000 stores, with more than half located in third-tier cities and below, and plans to increase its franchise model, expecting franchise-related revenue to account for 80% of total revenue by 2024 [2][3]. Group 2: Financial Performance - The company's revenue for 2022, 2023, and 2024 was 2.199 billion, 3.348 billion, and 3.285 billion RMB, respectively, with net profits of 149 million, 388 million, and 329 million RMB [3]. - A slight revenue decline of 1.9% is projected for 2024, attributed to decreased franchise and self-operated store income [3]. - The number of closed franchise stores increased significantly in 2024, with 987 closures, indicating challenges in maintaining store performance [3]. Group 3: IPO and Market Strategy - The IPO was priced at HKD 113.12 per share, with a total issuance of 2.4113 million shares, and received a subscription multiple of nearly 3,400 times, raising approximately HKD 195 million [1]. - The company plans to allocate 25% of the raised funds to enhance digital capabilities and optimize membership management, 20% for product development, and 20% to strengthen supply chain capabilities [2]. - The company aims to expand its store network in lower-tier cities while facing intense competition in the ready-to-drink tea market [3].

Investment Rating - The report maintains a "Buy" rating for the company, Anta (2020 HK) [2][6][7] Core Views - The company's 2024 performance met market expectations, with revenue reaching 70.83 billion RMB, a year-on-year increase of 13.6%. The guidance for 2025 indicates revenue growth in the high single to double digits [6][9] - The company is focusing on enhancing its global multi-brand strategy, with significant growth expected in Southeast Asia and an expansion target for overseas business to contribute 15% within five years [6][9] - The report projects a target price of 113.3 HKD, corresponding to a 22x P/E ratio for 2025, reflecting a potential upside of 15.7% from the current price [6][7] Financial Overview - Revenue projections for the upcoming years are as follows: 62.36 billion RMB in 2023, 70.83 billion RMB in 2024, and 77.16 billion RMB in 2025, with growth rates of 16.2%, 13.6%, and 8.9% respectively [5][9] - Net profit is expected to be 10.24 billion RMB in 2023, increasing to 15.60 billion RMB in 2024, but projected to decrease to 14.08 billion RMB in 2025 [5][9] - The company has maintained a dividend payout ratio of over 50%, with a proposed final dividend of 1.18 HKD per share for 2024 [6][9] Brand Performance - Anta brand revenue grew by 10.6% to 33.52 billion RMB, while FILA brand revenue increased by 6.1% to 26.63 billion RMB, indicating strong performance in the high-end market [6][9] - Other brands contributed significantly, with a 53.7% increase in revenue to 10.68 billion RMB, driven by brands like Descente and Kolon [6][9] Market Position and Strategy - The company is enhancing its product mix by increasing the proportion of lower-margin footwear products, which has led to a slight decline in gross margin to 62.2% [6][9] - The management is optimistic about the upcoming sports events in 2024, which are expected to boost advertising and promotional expenditures [6][9]